Lamivudine-resistant HIVM184V is durably suppressed with dolutegravir plus lamivudine dual therapy in humanised mice

Medina-Moreno, S; Zapata, JC; Kashanchi, F; Le, NM; Hassounah, S; Mesplede, T; Oliveira, M; Davis, CC; Heredia, A

Heredia, A (corresponding author), Univ Maryland, Sch Med, Inst Human Virol, 725 W Lombard St, Baltimore, MD 21201 USA.

JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2020; 20 (): 316